Skip to main content

Aclarion, Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

ACON$1.75+5.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Changes in Stockholders’ Equity (Deficit)

Series B · Series C
Preferred Stock · Preferred Stock · Common Stock · Paid-In · Accumulated
Shares · Value · Shares · Value · Shares · Value · Capital · Deficit · Total
For the Nine Months Ended September 30, 2025
Balance, December 31, 2024930$–874$–1,370$*$52,232,368$(51,262,311)$970,057
Share-based compensation––––––55,897–55,897
Registered direct offerings of common stock––––19,144*5,167,927–5,167,927
Public offering of common stock and warrants––––16,048*14,554,545–14,554,545
Common stock issuance costs––––––(2,101,282)–(2,101,282)
Redemption of Series B preferred stock(930)–––––(1,213,590)–(1,213,590)
Conversion of C-series preferred stock to common stock––(874)–687*––*
Exercise of C-series warrants––––629*336,441–336,441
Warrant amendment––––––48,087–48,087
Alternative cashless exercise of B warrants––––544,2995(5)––
Round-up conversion related to reverse stock splits––––161*(1)–(1)
Net loss–––––––(2,037,436)(2,037,436)
Balance, March 31, 2025–$––$–582,338$6$69,080,387$(53,299,747)$15,780,645
Share-based compensation––––––28,360–28,360
Round-up conversion related to reverse stock splits––––33*––*
Common stock issuance costs––––––(18,150)–(18,150)
Net loss–––––––(1,600,757)(1,600,757)
Balance, June 30, 2025–$––$–582,371$6$69,090,597$(54,900,504)$14,190,098
Share-based compensation––––––16,746–16,746
Net loss–––––––(1,706,294)(1,706,294)
Balance, September 30, 2025–$––$–582,371$6$69,107,343$(56,606,798)$12,500,551
For the Nine Months Ended September 30, 2026
Balance, December 31, 2025–$––$–854,371$9$71,331,048$(58,495,940)$12,835,117
Share-based compensation––––––4,694–4,694
Registered direct offerings of common stock––––200,00021,035,998–1,036,000
Proceeds from direct offering of prefunded warrants––––––9,323,982–9,323,982
Exercise of prefunded warrants––––1,390,50014(14)––
Common stock issuance costs––––––(691,739)–(691,739)
Net loss–––––––(2,853,575)(2,853,575)
Balance, March 31, 2026–$––$–2,444,871$25$81,003,969$(61,349,515)$19,654,479
Share-based compensation––––––102,117–102,117
Exercise of prefunded warrants––––17,379*––*
Common stock issuance costs––––––(6,325)–(6,325)
Net loss–––––––(2,747,551)(2,747,551)
Balance, June 30, 2026–$––$–2,462,250$25$81,099,761$(64,097,066)$17,002,720
Share-based compensation––––––424,821–424,821
Exercise of prefunded warrants––––420,1214(4)––
Net loss–––––––(2,622,035)(2,622,035)
Balance, September 30, 2026–$––$–2,882,371$29$81,524,578$(66,719,101)$14,805,506
*Rounds to less than one dollar
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.